http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002094343-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2001-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1579e8838b059c14543db872ba22fcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca64eb6e9aafc4b78f243f8d8f6984c |
| publicationDate | 2002-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002094343-A1 |
| titleOfInvention | Topical dermal anaesthetic |
| abstract | A liquid composition applied transdermally for relief of pain comprising alcohol in an amount by weight of about 57 to about 91 percent; glycerin in an amount by weight of about 1 to about 12 percent; an analgesic agent in an amount by weight of about 2 to about 28 percent, the analgesic agent comprising a derivative of salicylic acid; methylsulfonylmethane in an amount by weight of about 0.02 to 5 percent; and emu oil in an amount by weight of about 0.01 to 3 percent, the liquid composition permeating skin to relieve pain. The composition further comprising, as an additional feature, aloe vera in an amount by weight of at least about 0.05 percent and having an amount by weight of about 0.05 to 4 percent. The composition features transdermal pain relief such that a patient can apply the analgesic agent directly to an area of pain without such side effects as stomach irritation which is normally associated with aspirin. The composition may be sprayed or rolled directly onto the painful area. Because of the unique formula, the composition is safe to vital internal organs, requires no mixing before use, and is shelf stable for marketing purposes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339492-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115546-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1613334-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115546-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015100348-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1613334-A2 |
| priorityDate | 2001-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.